Orodispersible tablets: therapeutic and technological advantages of development
Keywords:
bucodispersables comprimidos, FDDT's, Flashtab, Wowtab, Orasolv, Durasolv, AOC, QuickSolv, Zydis, dosis de flashAbstract
The orally disintegrating tablets are defined as non-coated tablets intended to be placed in the mouth where they disperse rapidly before being swallowed. These formulations are known by the acronym FDDT's (Fast Dissolving Disintegrating Tablets). They are useful for administration to patients with swallowing difficulties, have a high acceptance by the patient, improve bioavailability of the active ingredient and represent a new alternative for the pharmaceutical industry. Among its disadvantages include limited knowledge by the patient, low mechanical strength, increased susceptibility to degradation by temperature and humidity; lack sometimes bioequivalence with conventional formulations, and the difficulty of obtaining prolonged release or delayed active ingredient. At the technological level, there are several processes that can be applied in their preparation. With classical methods of tabletting, by proper selection of excipients and the variables of the compression stage a tablet in which there is a balance between hardness and disintegration are obtained. Flashtab, Wowtab, Orasolv and Durasolv: They have a number of new technologies emerged. Another option is the use of freeze drying techniques, but has the disadvantage of its high cost. Some special patented technologies such as Lyoc, QuickSolv and Zydis. Finally, these tablets may be made by the method of Crosslinked polymers, also known as FlashDose and is based on the formation of a matrix of interwoven threads sugars.Downloads
References
Real Farmacopea Española, 3ª Ed. (2005). “Formas farmacéuticas: comprimidos” pag.650.
FDA. ” Guidance for industry: Orally disintegrating tablets”. Abril 2007.
Robin H.Bogner (2002). “Fast dissolving tablets”. US pharmacist, 27:34-43.
Fu Y, Yang S, Jeong SH, Kimura S, Park K (2004). “Orally fast disintegrating tablets: Development, technologies, taste-masking and clinical studies”. Critical Rewiev Therapy Drug Carrier System, 21: 433-76.
Lindgren S, Janzon L (1993). “Dysphagia: Prevalence of swallowing complaints and clinical findings”. Medical Clinic of North America; 73:3-5.
Maureen Mistry (2009). “Application-related properties of a new fast dispersable excipient”. Pharmaceutical Technology Europe, Vol.21 Nº 1
Grace Uko-Ekpenyong. (2006). “Improving medication adherence with orally disintegrating tablets”. Nursing, volume 36. nº 9, 20-21.
Pfister, William R.; Ghosh, Tapash K (2005). “Orally disintegrating tablets: products, technologies, and development issues: this review article discusses orally disintegrating tablets and their manufacturing technologies, development issues, and future trends”. Pharmaceutical Technology.
Srikonda Venkateswara Sastry, Janaki Ram Nyshadham, Joseph A. Fix 2000). “Recent technological advances in oral a drug delivery – a review”. PSTT Vol. 3, No. 4, 138 -145.
Chatap V.K., Gupta R.D., Jaiswal N.R., Patidar V.S. and Gupta V.B (2007). “Recent advances in mouth disintegratin tablet technology”. Asian Journal Of Pharmaceutics.
Robin H. Bogner, Megan F. Wilkosz (2002). ”Fast-Dissolving Tablets”. U.S. Pharmacist. 34-43.
Bogner RH, Wilkosz, MF (2009). Fast-Dissolving Tablets. U.S. Pharmacist.Fast Dissolving disintegrating tablets with isomalt. Pharmaceutical Technology Europe. 25-28
Sandri, Guiseppina; Bonferoni, Maria Cristina; Ferrari, Franca; Rossi Silvia; Caramella, Carla (2006). “Differentiating Factors between Oral Fast-Dissolving Technologies”. American Journal of Drug Delivery. Vol. 4(4) 249-262.
Dali Shukla, Subhashis Chakraborty, Sanjay Singh, Brahmeshwar Mishra (2009). “Mouth Dissolving Tablets I:An overview or Formulation Tecnology”. Scientia Pharmaceutica.
Suresh Bandari, Rajendar Kumar Mittapalli, Ramesh Gannu, Yamsani Madhusudan Rao (2008). “Orodispersible tablets: An overview”. Asian Journal Of Pharmaceutics.
http://www.cimalabs.com/technology/orasolv (20/9/2008)
http://www.cimalabs.com/technology/durasolv (20/9/2008)
Michael J. Rathbone, Jonathan Hadgraft, Michael S. Roberts. “Modified-Release Drug Delivery Technology”. Cap. 15: The Zydis Oral Fast-Dissolving Dosage Form. 191-199. Editorial Marcel Dekker, NY.
Fast Dissolving Drug Delivery Sistems: An Update.
Kurt H. Bauer (2007). “A new economical method for producing fast-melting lamina-like dosage forms”. Pharmaceutical Technology Europe.
Deepak Kaushik, Harish Dureja, and T.R. Saini (2004). “Orally Disintegrating tablets”. Tablet capsules.
Michael J. Rathbone, Jonathan Hadgraft, Michael S. Roberts. “Modified-Release Drug Delivery Technology”. Cap. 16: Orasolv and Durasolv. 204-215. Editorial Marcel Dekker, NY.
Manufacturing technology choices for mouth dissolving tablets: mouth dissolving tablets have great potential in the pharmaceutical industry and are prepared using various techniques such as freeze-drying, spray drying and tablets molding. Pharmaceutical Technology, 2003.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).